Shane Stecklein
www.aacr.org
0000-0001-8322-5886
University of Kansas Cancer Center
3 papers found
Refreshing results…
Tumor-Infiltrating Lymphocytes Refine Outcomes in Triple-Negative Breast Cancer Treated with Anthracycline-Free Neoadjuvant Chemotherapy
ctDNA and residual cancer burden are prognostic in triple-negative breast cancer patients with residual disease
Impact of low versus negative estrogen/progesterone receptor status on clinico-pathologic characteristics and survival outcomes in HER2-negative breast cancer
Missing publications? Search for publications with a matching author name.